Hydrogen sulfide is involved in dexamethasone-induced hypertension in rat

被引:46
|
作者
Bianca, Roberta d'Emmanuele di Villa [1 ]
Mitidieri, Emma [1 ]
Donnarumma, Erminia [1 ]
Tramontano, Teresa [1 ]
Brancaleone, Vincenzo [2 ]
Cirino, Giuseppe [1 ]
Bucci, Mariarosaria [1 ]
Sorrentino, Raffaella [1 ]
机构
[1] Univ Naples Federico II, Dept Pharm, I-80131 Naples, Italy
[2] Univ Basilicata, Dept Sci, I-85100 Potenza, Italy
来源
关键词
Glucocorticoid-induced hypertension; EDHF; Hydrogen sulfide; Mesentery; Carotid artery; Rat; VASCULAR SMOOTH-MUSCLE; GLUCOCORTICOID-INDUCED HYPERTENSION; HYPERPOLARIZING FACTOR; NITRIC-OXIDE; ARTERY; H2S; RELAXATION; ACTIVATION; REACTIVITY; CONTRIBUTE;
D O I
10.1016/j.niox.2014.11.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glucocorticoid (GC)-induced hypertension is a common clinical problem still poorly understood. The presence of GC receptor (GR) in vascular smooth muscle and endothelial cells suggests a direct role for GC in vasculature. In response to hemodynamic shear stress, endothelium tonically releases nitric oxide (NO), endothelial-derived hyperpolarizing factor (EDHF) and prostacyclin contributing to vascular homeostasis. Recently, hydrogen sulfide (H2S) has been proposed as a candidate for EDHF. H2S is endogenously mainly formed from L-cysteine by the action of cystathionine-beta-synthase (CBS) and cystathionine-gamma-lyase (CSE). It plays many physiological roles and contributes to cardiovascular function. Here we have evaluated the role played by H2S in mesenteric arterial bed and in carotid artery harvested from rats treated with vehicle or dexamethasone (DEX; 1.5 mg/kg/day) for 8 days. During treatments systolic blood pressure was significantly increased in conscious rats. EDHF contribution was evaluated in ex-vivo by performing a concentration response curve induced by acetylcholine (Ach) in presence of a combination of indomethacin and L-NG-Nitroarginine methyl ester in both vascular districts. EDHF-mediated relaxation was significantly reduced in DEX-treated group in both mesenteric bed and carotid artery. EDHF-mediated relaxation was abolished by pre-treatment with both apamin and charybdotoxin, inhibitors of small and big calcium-dependent potassium channels respectively, or with propargylglycine, inhibitor of CSE. Western blot analysis revealed a marked reduction in CBS and CSE expression as well as H2S production in homogenates of mesenteric arterial bed and carotid artery from DEX-treated rats. In parallel, H2S plasma levels were significantly reduced in DEX group compared with vehicle. In conclusion, an impairment in EDHF/H2S signaling occurs in earlier state of GC-induced hypertension in rats suggesting that counteracting this dysfunction may be beneficial to manage DEX-associated increase in blood pressure. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:80 / 86
页数:7
相关论文
共 50 条
  • [21] The anti-oxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat
    Zhang, Y
    Croft, KD
    Mori, TA
    Schyvens, CG
    McKenzie, KUS
    Whitworth, JA
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (5-6) : A38 - A38
  • [22] Prenatal dexamethasone-induced programmed hypertension and renal programming
    Sheen, Jiunn-Ming
    Yu, Hong-Ren
    Tiao, Mao-Meng
    Chen, Chih-Cheng
    Huang, Li-Tung
    Chang, Hsin-Yu
    Tain, You-Lin
    [J]. LIFE SCIENCES, 2015, 132 : 41 - 48
  • [23] Role of xanthine oxidase in dexamethasone-induced hypertension in rats
    Vickers, J. J.
    Ong, S. L. H.
    Zhang, Y.
    McKenzie, K. U. S.
    Whitworth, J. A.
    [J]. HYPERTENSION, 2007, 49 (06) : 1474 - 1475
  • [24] Inhibition of tyrosine hydroxylase reduces dexamethasone-induced hypertension
    Soto-Pina, Alexandra Estela
    Kadapakkam, Sheela
    Mehring, Cinthya
    Hinojosa-Laborde, Carmen
    Strong, Randy
    [J]. FASEB JOURNAL, 2011, 25
  • [25] Role of xanthine oxidase in dexamethasone-induced hypertension in rats
    Ong, Sharon L. H.
    Vickers, Janine J.
    Zhang, Yi
    McKenzie, Katja U. S.
    Walsh, Claire E.
    Whitworth, Judith A.
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (5-6) : 517 - 519
  • [26] PLASMA-CONCENTRATIONS, RENAL EXCRETION, AND TISSUE RELEASE OF PROSTAGLANDINS IN THE RAT WITH DEXAMETHASONE-INDUCED HYPERTENSION
    NASJLETTI, A
    ERMAN, A
    CAGEN, LM
    BAER, PG
    MATTHEWS, C
    KILLMAR, JT
    [J]. ENDOCRINOLOGY, 1984, 114 (03) : 1033 - 1040
  • [27] The NAD(P)H oxidase inhibitor apocynin reverses and prevents dexamethasone-induced hypertension in the rat
    Hu, L
    Zhang, Y
    Lim, PS
    Schyvens, CG
    McKenzie, KU
    Whitworth, JA
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2005, 32 (07) : A20 - A21
  • [28] Xanthine oxidase activity in the dexamethasone-induced hypertensive rat
    Wallwork, CJ
    Parks, DA
    Schmid-Schönbein, GW
    [J]. MICROVASCULAR RESEARCH, 2003, 66 (01) : 30 - 37
  • [29] DEXAMETHASONE-INDUCED ALTERATIONS IN THE GLYCOSPHINGOLIPIDS OF RAT-KIDNEY
    DAHIYA, R
    BRASITUS, TA
    [J]. LIPIDS, 1988, 23 (09) : 863 - 868
  • [30] Ultrastructural Changes Associated With Dexamethasone-Induced Ocular Hypertension in Mice
    Overby, Darryl R.
    Bertrand, Jacques
    Tektas, Ozan-Yueksel
    Boussommier-Calleja, Alexandra
    Schicht, Martin
    Ethier, C. Ross
    Woodward, David F.
    Stamer, W. Daniel
    Luetjen-Drecoll, Elke
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (08) : 4922 - 4933